ARCHIVES

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 45 | December 5, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Finds Physician Recommendation Drives Patient Demand For ABMT

July 19, 1996

Tipping Resigned Forom ACS Following Volunteer Discontent

September 27, 1991

NCI Cooperative Group Clinical Trials Approved

June 26, 2009

NCI Cooperative Group, Cancer Center Trials Listed

October 31, 2008

In Brief: Cancer An Alteration In Gene Expression, Not Change In Structure, Tulane Biologist Reports

March 27, 1981

In Brief: Hammer Okay, Panel’s Pittsburgh Meeting Rescheduled For Oc 23; Campbell Leaves AICR

July 17, 1987